CJC 1295 — GENETICA

DESCRIPTION: CJC-1295, also known as CJC-1295 DAC (Drug Affinity Complex), is a synthetic peptide that stimulates the release of growth hormone (GH) in the body. It works by increasing the production and secretion of GH from the pituitary gland. CJC-1295 is a modified form of growth hormone-releasing hormone (GHRH) and has a longer half-life, allowing for sustained stimulation of GH release.

CJC-1295 works by binding to specific receptors in the pituitary gland, which triggers the release of GH. This can lead to various benefits, including increased muscle mass, improved fat loss, enhanced recovery, and anti-aging effects.

One notable feature of CJC-1295 is its ability to increase the levels of insulin-like growth factor-1 (IGF-1), a hormone that plays a crucial role in growth and development. Elevated IGF-1 levels can contribute to muscle growth, tissue repair, and overall health.

CJC-1295 is typically administered via subcutaneous injection. The dosage and frequency of administration can vary depending on individual needs and goals. It’s important to note that CJC-1295 is not approved for medical use and is considered a research chemical. Therefore, it should only be used under the guidance of a healthcare professional or qualified researcher.

DOSAGE: The optimal dosage of CJC-1295 can vary depending on individual factors such as age, weight, and specific goals. However, a common dosage range for CJC-1295 is typically between 1-2 milligrams (mg) per week, divided into multiple injections. It is usually administered via subcutaneous injection. It’s important to note that CJC-1295 is not approved for medical use and should only be used under the guidance of a healthcare professional or qualified researcher. They can provide personalized dosage recommendations based on your specific needs and goals. It’s crucial to follow their guidance and monitor for any potential side effects or interactions.